Literature DB >> 21827904

Spinocerebellar ataxia type 2.

Georg W J Auburger1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 21827904     DOI： 10.1016/B978-0-444-51892-7.00026-7

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN： 0072-9752


× No keyword cloud information.
  27 in total

1.  Selective Forces Related to Spinocerebellar Ataxia Type 2.

Authors:  Lucas Schenatto Sena; Raphael Machado Castilhos; Eduardo Preusser Mattos; Gabriel Vasata Furtado; José Luiz Pedroso; Orlando Barsottini; Maria Marla Paiva de Amorim; Clecio Godeiro; Maria Luiza Saraiva Pereira; Laura Bannach Jardim
Journal:  Cerebellum       Date:  2019-04       Impact factor: 3.847

Review 2.  The role for alterations in neuronal activity in the pathogenesis of polyglutamine repeat disorders.

Authors:  Ravi Chopra; Vikram G Shakkottai
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

3.  ATXN3, ATXN7, CACNA1A, and RAI1 Genes and Mitochondrial Polymorphism A10398G Did Not Modify Age at Onset in Spinocerebellar Ataxia Type 2 Patients from South America.

Authors:  Fernanda S Pereira; Thais L Monte; Lucas D Locks-Coelho; Amanda S P Silva; Orlando Barsottini; José L Pedroso; Mario Cornejo-Olivas; Pilar Mazzetti; Clecio Godeiro; Fernando R Vargas; Maria-Angélica F D Lima; Hélio van der Linden; Maria Betânia Pereira Toralles; Paula F V Medeiros; Erlane Ribeiro; Pedro Braga-Neto; Diego Salarini; Raphael M Castilhos; Maria-Luiza Saraiva-Pereira; Laura Bannach Jardim
Journal:  Cerebellum       Date:  2015-12       Impact factor: 3.847

4.  Corticomuscular Coherence: a Novel Tool to Assess the Pyramidal Tract Dysfunction in Spinocerebellar Ataxia Type 2.

Authors:  Luis Velázquez-Pérez; Johannes Tünnerhoff; Roberto Rodríguez-Labrada; Reidenis Torres-Vega; Paolo Belardinelli; Jacqueline Medrano-Montero; Arnoy Peña-Acosta; Nalia Canales-Ochoa; Yaimeé Vázquez-Mojena; Yanetza González-Zaldivar; Georg Auburger; Ulf Ziemann
Journal:  Cerebellum       Date:  2017-04       Impact factor: 3.847

Review 5.  Recent advances in RNA interference therapeutics for CNS diseases.

Authors:  Pavitra S Ramachandran; Megan S Keiser; Beverly L Davidson
Journal:  Neurotherapeutics       Date:  2013-07       Impact factor: 7.620

Review 6.  The autosomal dominant spinocerebellar ataxias: emerging mechanistic themes suggest pervasive Purkinje cell vulnerability.

Authors:  Katherine E Hekman; Christopher M Gomez
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-08-18       Impact factor: 10.154

7.  Progression of microstructural damage in spinocerebellar ataxia type 2: a longitudinal DTI study.

Authors:  M Mascalchi; N Toschi; M Giannelli; A Ginestroni; R Della Nave; E Nicolai; A Bianchi; C Tessa; E Salvatore; M Aiello; A Soricelli; S Diciotti
Journal:  AJNR Am J Neuroradiol       Date:  2015-04-16       Impact factor: 3.825

8.  Contextualizing the pathology in the essential tremor cerebellar cortex: a patholog-omics approach.

Authors:  Elan D Louis; Chloë A Kerridge; Debotri Chatterjee; Regina T Martuscello; Daniel Trujillo Diaz; Arnulf H Koeppen; Sheng-Han Kuo; Jean-Paul G Vonsattel; Peter A Sims; Phyllis L Faust
Journal:  Acta Neuropathol       Date:  2019-07-17       Impact factor: 17.088

9.  Generation of human-induced pluripotent stem cells to model spinocerebellar ataxia type 2 in vitro.

Authors:  Guangbin Xia; Katherine Santostefano; Takashi Hamazaki; Jilin Liu; S H Subramony; Naohiro Terada; Tetsuo Ashizawa
Journal:  J Mol Neurosci       Date:  2012-12-09       Impact factor: 3.444

10.  Torpedo formation and Purkinje cell loss: modeling their relationship in cerebellar disease.

Authors:  Elan D Louis; Sheng-Han Kuo; Jean-Paul G Vonsattel; Phyllis L Faust
Journal:  Cerebellum       Date:  2014-08       Impact factor: 3.847
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.